DE69535565D1 - Verwendung von desulfatiertem Heparin - Google Patents

Verwendung von desulfatiertem Heparin

Info

Publication number
DE69535565D1
DE69535565D1 DE69535565T DE69535565T DE69535565D1 DE 69535565 D1 DE69535565 D1 DE 69535565D1 DE 69535565 T DE69535565 T DE 69535565T DE 69535565 T DE69535565 T DE 69535565T DE 69535565 D1 DE69535565 D1 DE 69535565D1
Authority
DE
Germany
Prior art keywords
desulfated heparin
desulfated
heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535565T
Other languages
English (en)
Other versions
DE69535565T2 (de
Inventor
Saburo Hara
Keiichi Yoshida
Masayuki Ishihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Application granted granted Critical
Publication of DE69535565D1 publication Critical patent/DE69535565D1/de
Publication of DE69535565T2 publication Critical patent/DE69535565T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69535565T 1994-07-01 1995-07-03 Verwendung von desulfatiertem Heparin Expired - Lifetime DE69535565T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15125894 1994-07-01
JP15125894 1994-07-01

Publications (2)

Publication Number Publication Date
DE69535565D1 true DE69535565D1 (de) 2007-09-27
DE69535565T2 DE69535565T2 (de) 2008-05-08

Family

ID=15514737

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69531945T Expired - Lifetime DE69531945T2 (de) 1994-07-01 1995-07-03 Verfahren zur herstellung von desulfatiertem polysaccharid und desulfatiertem heparin
DE69535565T Expired - Lifetime DE69535565T2 (de) 1994-07-01 1995-07-03 Verwendung von desulfatiertem Heparin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69531945T Expired - Lifetime DE69531945T2 (de) 1994-07-01 1995-07-03 Verfahren zur herstellung von desulfatiertem polysaccharid und desulfatiertem heparin

Country Status (6)

Country Link
US (3) US6140481A (de)
EP (2) EP0769502B1 (de)
JP (1) JP3929486B2 (de)
DE (2) DE69531945T2 (de)
HU (1) HU218600B (de)
WO (1) WO1996001278A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5657722A (en) * 1996-01-30 1997-08-19 Thomas J. Hollis System for maintaining engine oil at a desired temperature
DE69739750D1 (de) 1996-07-23 2010-03-18 Seikagaku Kogyo Co Ltd Neue laktosamin-oligosaccharide und verfahren zu ihrer herstellung
EP1022289B1 (de) * 1998-07-31 2004-07-07 Seikagaku Corporation Neues glycosaminoglycan und dieses enthaltendes arzneimittel
CA2484374C (en) * 2002-05-09 2011-05-17 Hemoteq Gmbh Medical products comprising a haemocompatible coating, production and use thereof
ITMI20042068A1 (it) * 2004-10-29 2005-01-29 Opocrin Spa Nuovo uso di eparine a bassissimo peso molecolare
US20090012278A1 (en) 2005-03-14 2009-01-08 Seikagaku Corporation Promoter For Hard Tissue Formation
JP2007254316A (ja) * 2006-03-22 2007-10-04 Seikagaku Kogyo Co Ltd Ｈａマトリックス形成阻害剤
WO2009059284A2 (en) * 2007-11-02 2009-05-07 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
IT1398549B1 (it) 2010-03-05 2013-03-01 Jasper Llc Silil- derivati di polisaccaridi
WO2011130697A2 (en) 2010-04-16 2011-10-20 Momenta Pharmaceuticals, Inc. Tissue targeting
US10017585B2 (en) 2010-06-17 2018-07-10 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
CA2910837A1 (en) 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
RS20171030A1 (sr) 2017-10-12 2019-04-30 Pavlovic Bojan F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1169888B (it) * 1983-10-25 1987-06-03 Italfarmaco Spa Glicosaminoglicani modificati dotati di attivita' antitrombotica
US5132223A (en) * 1983-11-10 1992-07-21 Thomas Jefferson University Process and medium for cloning and long-term serial cultivation of adult human endothelial cells
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
JPH0240399A (ja) * 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
AR245455A1 (es) * 1989-08-18 1994-01-31 Ajorca Sa Procedimiento para la obtencion de derivados de heparina,parcial o totalmente n-acetilados en el resto glucosaminico y productos asi obtenidos excluidos sus usos farmaceuticos.
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
FI921689A (fi) * 1991-04-16 1992-10-17 Seikagagu Kogyo Kabushiki Kais Oligosackarid med affinitet foer fibroblasttillvaextfaktor och foerfarande foer framstaellning av denna
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
US5296471A (en) * 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
AU2435795A (en) * 1994-05-06 1995-11-29 Glycomed Incorporated O-desulfated heparin derivatives, methods of making and uses thereof
US5990097A (en) * 1996-07-29 1999-11-23 Cavalier Pharmaceuticals Methods of treating asthma with o-desulfated heparin

Also Published As

Publication number Publication date
DE69535565T2 (de) 2008-05-08
US6809086B2 (en) 2004-10-26
HU218600B (hu) 2000-10-28
EP0769502A4 (de) 1999-03-10
US6140481A (en) 2000-10-31
DE69531945T2 (de) 2004-08-19
HUT76426A (en) 1997-08-28
WO1996001278A1 (fr) 1996-01-18
EP1371666B1 (de) 2007-08-15
US20030149253A1 (en) 2003-08-07
EP0769502A1 (de) 1997-04-23
HU9603606D0 (en) 1997-02-28
US6545136B1 (en) 2003-04-08
DE69531945D1 (de) 2003-11-20
JP3929486B2 (ja) 2007-06-13
EP0769502B1 (de) 2003-10-15
EP1371666A3 (de) 2004-01-28
EP1371666A2 (de) 2003-12-17

Similar Documents

Publication Publication Date Title
DE69533361D1 (de) Umsetzung von kohlenwasserstoffen
DE69527527D1 (de) Verwendung von omega-hydrofluoralkylether
DE69636313D1 (de) Verwendung von Kristallformen von 2-Methylthienobenzodiazepinen
DE59905858D1 (de) Verwendung von pit-emulsionen
DE69626729D1 (de) Kombination von Datenwerten
DE69535565D1 (de) Verwendung von desulfatiertem Heparin
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
ATA55695A (de) Thrombosemittel
DE69826752D1 (de) Verwendung von Polymerfilme
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
DE69707617T2 (de) Optischer Frequenzstabilisator
DE69519381D1 (de) Modifizierung von ölen
DE69731897D1 (de) Decken-einbau von beleuchtungs- oder anderen geräten
DE59702736D1 (de) Verwendung von textilausrüstungsmitteln
DE69711223T2 (de) Verwendung von cordia dichotoma extrakten
DE59401861D1 (de) Verwendung von ferrocen
DE69507608D1 (de) Suspensionspolymerisation von tetrafluorethylen
DE69821651D1 (de) Management von vermittlungstechnischen abschlusseinheiten
DK0797547T3 (da) Fremstilling af glasfiberprodukter
DE59501871D1 (de) Monocarbonsäureamide von Polyaminen
DK36193D0 (da) Fremgangsmaade
DE59704755D1 (de) Verwendung von Dialkylethern
DE69739815D1 (de) Verwendung von Getriebeölen
DE59507095D1 (de) Verwendung von detergensgemischen
DE862581T1 (de) Heparinchromatographie von erythropoietinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition